tm
Seeing Is Believing
tm
Seeing Is Believing
LCTX is currently covered by 1 analysts with an average price target of $6.27. This is a potential upside of $5.7 (1000%) from yesterday's end of day stock price of $0.57.
Lineage Cell Therapeutics's activity chart (see below) currently has 0 price targets and 6 ratings on display. The stock rating distribution of LCTX is 100% BUY.
Highest price target for LCTX is $7, Lowest price target is $7, average price target is $6.27.
Most recent stock forecast was given by JOSEPH PANTGINIS from HCWAINWRIGHT on 06-May-2024. First documented stock forecast 10-Mar-2023.
Currently out of the existing stock ratings of LCTX, 6 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$7
$5.98 (586.27%)
$7
6 months 23 days ago
(06-May-2024)
0/6 (0%)
$5.7 (438.46%)
What is LCTX (Lineage Cell Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on LCTX (Lineage Cell Therapeutics) with a proven track record?
Which analyst has the most public recommendations on LCTX (Lineage Cell Therapeutics)?
Which analyst is the currently most bullish on LCTX (Lineage Cell Therapeutics)?
